Key Financial Data Of Reporting Company

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7339470

Concept 2024-01-01 to
2024-03-31
As at
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-03-31
As at
2023-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
1,377,000,000 JPY
6,120,000,000 JPY
1,167,000,000 JPY
Ordinary profit (loss)
229,000,000 JPY
-1,248,000,000 JPY
-242,000,000 JPY
Net assets
7,424,000,000 JPY
6,739,000,000 JPY
7,857,000,000 JPY
Total assets
12,997,000,000 JPY
13,220,000,000 JPY
14,404,000,000 JPY
Basic earnings (loss) per share
9.41
-76.25
-5.59
Diluted earnings per share
Equity-to-asset ratio
0.571 xbrli:pure
0.510 xbrli:pure
0.545 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.